Robert F. Kennedy, Jr. claims that he is "fiercely pro-vaccine." His words and actions say otherwise, for instance his Indiegogo campaign to raise money to promote antivaccine misinformation.
Last week, the FDA released final regulatory guidance regarding freestanding stem cell clinics. The new regulatory framework appears custom-made to allow the FDA to crack down on quack stem cell clinics. But will it?
Yesterday, I wrote about how right-to-try and an unethical offshore vaccine trial are part of free market fundamentalists' attack on the FDA. Here's another example, the "right to choose medicine."
I've discussed so-called "right-to-try" laws, which promise to speed experimental drugs to terminally ill patients, but which in reality are about weakening and bypassing the FDA. Now über-Libertarian Peter Thiel is trying a new tactic to bypass the FDA by organizing an offshore clinical trial of a new herpes vaccine based on dubious science and not overseen by an IRB to protect patients. Both right-to-try and this trial are different fronts in the same fundamentalist free market war on FDA regulation.
In January, Robert F. Kennedy, Jr. bragged about having met with President-Elect Donald Trump about chairing a presidential commission on vaccine safety. In the intervening eight months, no commission has materialized, but, if you can believe his account, Kennedy has been meeting with government officials to promote his antivaccine views at the behest of the Trump administration. As long as that continues, pro-science advocates can't afford to rest easy.
Chiropractors and acupuncturists have lobbied for a greater role in treating pain. They might well have won it. Last week, the FDA released proposed changes Wednesday to its blueprint on educating health care providers about treating pain, which now recommend that doctors learn about chiropractic care and acupuncture as therapies that might help patients avoid opioids. There’s still time to stop this, but you have to write the FDA.
This week, the FDA sent warning letters to 14 companies making unsupported claims that their products can treat cancer. Given the new administration's determination to deregulate almost everything, but especially the FDA, is this the last time in the foreseeable future that such a crackdown will occur?
Last month, the Texas Medical Board fined Houston cancer quack Dr. Stanislaw Burzynski and placed his practice under supervision. It did not strip him of his medical license, as he deserves. The result is that families of children with terminal cancer are once again raising hundreds of thousands of dollars to follow his siren song of false hope.
Ill-advised right-to-try bills are spreading like kudzu through state legislatures. Now federal legislators want to insert right-to-try language into the bill that funds FDA drug approval. Given the support of powerful Republicans for right-to-try, is it too late to stop this juggernaut and protect patients?
In less than two weeks, the Trump administration will have passed that magical "first 100 days" marker. Let's check in and see how Donald Trump is shaping federal biomedical policy thus far. Hint: It's deregulation über alles.